Regenxbio IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 10.12 USD | 16,19 USD | 5,455 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 24,273 USD | 6 | 5 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 64.020.245 | 17,95 | 2,94 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Regenxbio Inc
Mitarbeiter 371
Handelsplatz NASDAQ
Ticker Symbol RGNX
IPO Datum 2015-09-17
Adresse 9804 Medical Center Drive, Rockville, MD, United States, 20850
Webseite https://www.regenxbio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Curran M. Simpson M.S. | President, CEO & Director |
| 2 | Mr. Patrick J. Christmas II, J.D. | Executive VP & Chief Strategy and Legal Officer |
| 3 | Dr. Stephen Pakola M.D. | Executive VP & Chief Medical Officer |
| 4 | Mr. Mitchell Chan M.B.A. | Executive VP & CFO |
| 5 | Mr. Craig Malzahn | Executive VP of Product Development & CTO |
| 6 | Dr. Olivier Danos Ph.D. | Executive VP & Chief Scientific Officer |
| 7 | Ms. Shiva G. Fritsch | Chief Communications & People Officer |
| 8 | Dr. Ram Palanki Pharm.D. | Executive VP & Chief Commercial Officer |
| 9 | Ms. Nina Hunter | SVP of Global Regulatory Strategy and Quality |
| 10 | Dr. Jahannaz Dastgir D.O. | Clinical Development Lead |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Redmile Group, LLC | 0,00% | 0,00 Mio. USD |
| 3 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 5 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 6 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 9 | Integral Health Asset Management, LLC | 0,00% | 0,00 Mio. USD |
| 10 | Qube Research & Technologies | 0,00% | 0,00 Mio. USD |
| 11 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 12 | AQR Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 13 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 14 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 15 | Nuveen, LLC | 0,00% | 0,00 Mio. USD |
| 16 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 17 | Pale Fire Capital SE | 0,00% | 0,00 Mio. USD |
| 18 | 22NW, LP | 0,00% | 0,00 Mio. USD |
| 19 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 20 | Stifel Financial Corp | 0,00% | 0,00 Mio. USD |